The prevalence rates of the use of new technologies in this present study for mobile health applications, flash monitoring, blood glucose monitoring, and insulin pumps among the studied patients with diabetes were 13.5%, 12.2%, 11.3%, and 4%, respectively. The gene discussed is INS; the disease is diabetes mellitus.